Total Clarity Wealth Management, Inc. Vascular Biogenics Ltd. Transaction History

Total Clarity Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$1.22 - $1.95 $4,880 - $7,800	4,000 New	4,000 $6,000
Q1 2022 Apr 29, 2022	SELL	$1.15 - $1.97 $4,600 - $7,880	-4,000 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$1.94 - $2.55 $7,760 - $10,200	4,000 New	4,000 $8,000
Q2 2021 Jul 26, 2021	SELL	$1.69 - $2.67 $6,760 - $10,680	-4,000 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$1.79 - $2.91 $7,160 - $11,640	4,000 New	4,000 $8,000
Q1 2020 Apr 24, 2020	SELL	$0.96 - $1.57 $3,840 - $6,280	-4,000 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$1.1 - $1.32 $4,400 - $5,280	4,000 New	4,000 $5,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.